Vasculitis leucocitoclástica tras la vacunación en una paciente con enfermedad inflamatoria intestinal

  1. María Fernández Prada 1
  2. Paula Alonso Penanes 2
  3. Patricia Morales del Burgo 3
  4. I. Pérez Martínez 3
  5. María Clara Villa del Amo 3
  1. 1 Hospital Vital Álvarez Buylla. Mieres, Asturias
  2. 2 Universidad de Oviedo. Oviedo, Asturias
  3. 3 Hospital Universitario Central de Asturias. Oviedo, Asturias
Zeitschrift:
Revista Española de Enfermedades Digestivas

ISSN: 2340-416 1130-0108

Datum der Publikation: 2019

Ausgabe: 111

Nummer: 5

Seiten: 402-404

Art: Artikel

DOI: 10.17235/REED.2019.5963/2018 DIALNET GOOGLE SCHOLAR

Andere Publikationen in: Revista Española de Enfermedades Digestivas

Zusammenfassung

Patients with inflammatory bowel disease are likely to receive immunomodulation treatment and therefore, should be properly vaccinated. Despite their proven safety, vaccines are not exempt from adverse reactions. The clinical case was a young female with ulcerative colitis under mesalazine treatment, who developed leukocytoclastic vasculitis following vaccination for pneumococci, varicella and hepatitis A. This adverse reaction after the previously mentioned vaccines is barely described in the literature and has never been reported in a patient with an underlying condition.